Back to search

United Kingdom· GB-APID-98311000001102

Ketek 400mg tablets

A telithromycin product containing telithromycin, registered in United Kingdom by Sanofi. The same ATC class is registered in 3 of our 19 countries.

ATC J01FA15

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedKetek 400mg tabletsATCJ01FA15REGISTER NO.GB-APID-98311000001102PACKS LISTED0CHECKEDOctober 2, 2026

Where it is registered

Telithromycin is registered in 3 of 19 countries.

Countries holding a registration under ATC J01FA15 (telithromycin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 2 of them publish a price we can compare per daily dose

Telithromycin · ATC J01FA15

3 / 19 countries

  • Belgiumprice
  • Finlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Telithromycin
Manufacturer
Sanofi
Country
United Kingdom (GB)
ATC code
J01FA15
ATC class
Telithromycin
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
October 2, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

445 interactions on record for telithromycin.

Graded by severity as the source publishes them — 155 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Telithromycin · interactions on record

445 records

  • 155 severe
  • 218 moderate
  • 8 minor
  • 64 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NaloxegolA06AH03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Telithromycin in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All telithromycin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/968524a1-1448-4186-96d6-a5808dc9cc5e
GET /v1/drugs/968524a1-1448-4186-96d6-a5808dc9cc5e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "98311000001102",
  "desc": "Ketek 400mg tablets (Sanofi)",
  "form": "Oral tablet",
  "vpid": "41955811000001102",
  "source": "dmd",
  "vtm_id": "777695004",
  "strength": "400 mg",
  "substance": "Telithromycin",
  "ingredient": "Telithromycin",
  "supplier_code": "9190711000001101"
}

See everything about telithromycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.